Let me re-phrase, they have no current operations and revenue from MEDICINAL hemp products.
They have primary market and operations in hemp food products, but the medicinal oil is still in r&d.
With a 20m raise, consequently increasing market cap, is a revenue stream from hemp food products worth the 60-70% premium at which traders got in at?
Dont get me wrong, i'm one of the lucky few that got 80k+ and no doubt EXL has a good business model, but how long til the primary product goes into production?
And is a stock in R&D worth your 60-70% premium?
DYOR, GLTAH
Let me re-phrase, they have no current operations and revenue...
Add EXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $6.505M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $10.01K | 2.002M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 3660204 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 7345956 | 17 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 892486 | ||
| Last updated 15.45pm 03/05/2024 ? | |||||
| EXL (ASX) Chart |